BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2025

  May 1, 2025

   · 

  19 min read
• Press Releases

  MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025

  May 1, 2025

   · 

  1 min read
• Press Releases

  NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

  May 1, 2025

   · 

  6 min read
• Press Releases

  Exact Sciences Announces First-Quarter 2025 Results

  May 1, 2025

   · 

  20 min read
• Press Releases

  Envoy Medical Reports on First Quarter 2025 Results

  Company Provides Update on Its Pivotal Clinical Study for Fully Implanted Cochlear Implant

  May 1, 2025

   · 

  13 min read
• Press Releases

  ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America

  May 1, 2025

   · 

  7 min read
• Press Releases

  Tris Pharma to Unveil Positive Phase 3 Results including a Strong Safety Profile Showcasing the Potential of Cebranopadol, an Investigational First-in-Class Dual-NMR Agonist for the Treatment of Pain, at the 2025 ASRA Annual Meeting

  May 1, 2025

   · 

  5 min read
• Press Releases

  Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

  May 1, 2025

   · 

  4 min read
• Press Releases

  BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure

  May 1, 2025

   · 

  7 min read
• Press Releases

  Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.

  May 1, 2025

   · 

  6 min read